Healthtech Startups

Cor.Sync provides a point-of-care diagnostic device for rapid measurement of ultrasensitive troponin in whole blood, enabling hospitals and emergency care teams to quickly diagnose cardiac infarction. The device uses AI-analyzed sensors and delivers quantitative results in 8 minutes without sample preparation.

1 investor

Cora is an AI-powered fitness coaching app that creates personalized training programs, recovery guidance, and nutrition plans. It integrates with wearables like Apple Watch and Garmin to adapt coaching based on real-time body data.

1 investor

CORA is a physical therapy provider whose clinicians deliver rehabilitation and physical therapy care to patients. This page invites former patients to share testimonials about their treatment experience.

1 investor

Coral Genomics develops laboratory tests that combine molecular, functional, and clinical data to guide treatment selection for patients with autoimmune diseases, including those resistant to existing therapies.

1 investor

Corbus Pharmaceuticals is a biopharmaceutical company developing therapies for critical stages of clinical development, with a focus on advancing patient-centered progress in drug development. The company is led by a senior leadership team with expertise in pharmaceutical research, regulatory affairs, and clinical development.

1 investor

Corcillum provides a cloud platform for medical image annotation and multi-physics modelling, serving researchers, clinical trials teams, healthcare AI organizations, and medical innovators who need to curate imaging data, perform AI-powered annotation, and conduct functional modelling.

1 investor

CordenPharma is a contract development and manufacturing organization (CDMO) providing high-quality integrated product solutions to pharmaceutical and biotechnology companies across the complete drug lifecycle.

1 investor

Cordex Systems develops SmartCuff, a medical device that repurposes blood pressure cuff technology as a linear sensor to detect early warning signs of heart disease. The device is designed for healthcare professionals and patients at risk of cardiovascular disease.

1 investor

Core Diagnostics offers diagnostic laboratory testing with sample collection services, including routine tests and diagnostic monitoring tests scheduled at defined intervals. The company serves individuals seeking medical diagnostic testing.

1 investor

Corealis Pharma is a contract development and manufacturing organization (CDMO) specializing in oral solid dosage formulation and GMP manufacturing for biotech companies developing complex therapies. The company provides services from early-stage formulation through clinical supply, with integrated R&D and manufacturing infrastructure based in Laval, Canada.

1 investor

Corelinesoft develops aview, a CT-based artificial intelligence software that assists radiologists in image interpretation and enables healthcare institutions to extract broader analytical insights from chest imaging data. The company serves hospitals, screening centers, and research institutions globally, with extensive experience in national lung cancer screening programs.

1 investor

Corentec (㈜코렌텍) develops orthopedic implants, including knee replacement systems such as its EXULT Knee System with CR, PS, CPS, and UCR tibial insert types. The company, which recently received US FDA approval for its UCR-type knee implant, is expanding into the US market.

1 investor

Core Schedule develops staff scheduling software for healthcare organisations, helping teams manage complex rosters and reduce administrative workload. The company serves hospitals and healthcare providers across New Zealand, Australia, and the USA.

1 investor

Core Innovation Capital (Core VC) is a venture capital firm that invests in early-stage companies building infrastructure for financial services and healthcare aimed at the mass market. It backs founders working to modernize wealth and health for everyday Americans.

1 investor

Cori Clinical builds an AI platform that automates the authoring and management of clinical trial documentation, including protocols, consent forms, and regulatory submissions. The platform serves clinical development teams by reducing manual document preparation and ensuring consistency across all trial-related paperwork.

1 investor

Coridea invests in and develops healthcare companies focused on patient-centric solutions. The firm provides capital and support to high-impact medical technology and healthcare ventures.

1 investor

Corify develops ACORYS, a cardiac mapping system for clinicians that performs real-time, beat-to-beat global cardiac mapping to help diagnose cardiac arrhythmias. The system is designed to visualize the entire heart quickly without maneuvering catheters during lengthy operating-room procedures.

1 investor

Corilus develops medical practice software for healthcare professionals — including GPs, specialists, pharmacists, dentists, nurses, physiotherapists, midwives, and residential care centers — through its CareConnect suite. The software manages electronic patient records, scheduling, billing, and connects providers with eHealth services, hospitals, and other care professionals, with a focus on the Belgian healthcare market.

1 investor

1 investor

Corion Biotech develops therapeutic solutions for women's health, with a focus on pregnancy-related disorders such as preeclampsia and fetal growth restriction. The company was founded as an academic spin-off from the University of Turin based on over two decades of translational research in obstetrics and gynecology.

1 investor

Corisma develops a fully implanted transcatheter mechanical circulatory support system for advanced heart failure patients, designed to bridge acute and chronic care with improved quality of life. The device eliminates the driveline and uses wireless, catheter-based technology to replace current standard-of-care treatment options.

1 investor

CORIT Medical develops a Class I single-use, handheld surgical device for inferior turbinate reduction, a procedure used to relieve nasal obstruction and improve breathing. The device is aimed at physicians performing the procedure in-office, targeting the US market where roughly 1 million such procedures occur annually.

1 investor

Cormeo provides an end-to-end software suite for creating, managing, exchanging, and distributing regulated medicinal product information across the life sciences sector, connecting industry, regulatory authorities, healthcare professionals, and patients. It supports regulatory standards such as eCTD, IDMP, ePI, and FHIR to help companies and agencies manage submissions, master data, and approvals.

1 investor

AeroRx is a clinical-stage biopharmaceutical company developing nebulized fixed-dose combination therapies (LABA/LAMA and triple LABA/LAMA/ICS) for moderate-to-severe COPD patients who are underserved by inhalers. Its pipeline targets high-risk respiratory patients, including older individuals and those with dexterity limitations who benefit from nebulized delivery.

1 investor